Bionorica is one of the world's leading manufacturers of herbal evidencebased medicines with activities in more than 50 countries. Approximately 1.500 employees work at 17 Bionorica sites around the world.
Bionorica uses the "phytoneering" philosophy to decode the potential of plants (phytos) through the use of state-of-the-art research and technology (engineering) resulting in highly effective drugs.
The topic of the Bionorica ethics business unit is cannabinoids. The goal of the therapeutic use of these drugs is to significantly improve quality of life of seriously ill patients suffering from cachexia, chemotherapy-induced nausea or emesis as well as spasticity or chronic pain.